SEC Comment Letter for Wave Life Sciences, (WVE) — May 5, 2026
Wave Life Sciences, Inc.
Date: May 5, 2026 · CIK: 0001631574 · Accession: 0000000000-26-004561
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-37627
Letter
Re: Wave Life Sciences Ltd. Preliminary Proxy Statement on Schedule 14A Filed April 15, 2026 File No. 001-37627 Dear Paul Bolno:
May 5, 2026
Paul Bolno Chief Executive Officer Wave Life Sciences Ltd. 7 Straits View #12-00 Marina One East Tower Singapore 018936
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Mark M. Bekheit, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 5, 2026 Paul Bolno Chief Executive Officer Wave Life Sciences Ltd. 7 Straits View #12-00 Marina One East Tower Singapore 018936 Re: Wave Life Sciences Ltd. Preliminary Proxy Statement on Schedule 14A Filed April 15, 2026 File No. 001-37627 Dear Paul Bolno: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mark M. Bekheit, Esq. </TEXT> </DOCUMENT>